Low bone mineral density in patients with type 1 diabetes: association with reduced expression of IGF1, IGF1R and TGFB1 in peripheral blood mononuclear cells

被引:26
作者
Costa de Souza, Karla Simone [1 ]
Galvao Ururahy, Marcela Abbott [1 ]
da Costa Oliveira, Yonara Monique [1 ]
Loureiro, Melina Bezerra [1 ]
Vital da Silva, Heglayne Pereira [1 ]
Bortolin, Raul Hernandes [1 ]
dos Santos, Fabricio Melo [1 ]
Luchessi, Andre Ducati [1 ]
Maciel Neto, Jose Jorge [2 ]
Arrais, Ricardo Fernando [3 ]
Crespo Hirata, Rosario Dominguez [4 ]
Almeida, Maria das Gracas [1 ]
Hirata, Mario Hiroyuki [4 ]
de Rezende, Adriana Augusto [1 ]
机构
[1] Univ Fed Rio Grande do Norte, Dept Clin & Toxicol Anal, Natal, RN, Brazil
[2] Univ Fed Rio Grande do Norte, Onofre Lopes Univ Hosp, Radiol Ctr, Natal, RN, Brazil
[3] Univ Fed Rio Grande do Norte, Dept Pediat, Natal, RN, Brazil
[4] Univ Sao Paulo, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil
关键词
type; 1; diabetes; low BMD; IGF1; IGF1R; TGFB1; mRNA expression; GENE-EXPRESSION; METABOLIC-CONTROL; GROWTH; CHILDREN; COMPLICATIONS; ADOLESCENTS; FRACTURES; GEOMETRY; MELLITUS; DISEASE;
D O I
10.1002/dmrr.2772
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The negative effects of type 1 diabetes (T1D) on growth factors of bone metabolism lead to a reduction in bone mineral density. This study aimed to evaluate the association between bone mineral density and insulin-like growth factor 1 (IGF1), insulin-like growth factor 1 receptor (IGF1R) and transforming growth factor beta 1 (TGFB1) expressions in children and adolescents with T1D. Moreover, the influences of age at diagnosis, time since diagnosis, glycaemic control and albuminuria on bone mineral density were investigated. Methods Eighty-six T1D children/adolescents (T1D group) and ninety normoglycaemic controls (normoglycaemic group) were included. T1D patients were analysed as a whole and also in subsets of patients with good glycaemic control (glycated hemoglobin concentration <= 7.5%) and with poor glycaemic control (glycated hemoglobin concentration >7.5%). Bone mineral density was assessed by dual energy x-ray absorptiometry. Glycaemic control, renal function and bone markers were also assessed. IGF1, IGF1R and TGFB1 expressions were determined in peripheral blood mononuclear cells by real-time polymerase chain reaction. Results Patients with T1D showed low bone mineral density and poor glycaemic control. Serum total calcium and urinary albumin-to-creatinine ratio were higher in patients with poor glycaemic control compared to those with good glycemic control (p=0.003 and p=0.035, respectively). There was a reduction of IGF1, IGF1R and TGFB1 expressions in the T1D patients and in the subset with poor glycaemic control compared to normoglycaemic controls (p<0.05). Conclusions The decreased IGF1, IGF1R and TGFB1 expressions in the T1D patients, who presented with T1D at an early age, had been diagnosed with T1D for a longer time, had poor glycaemic control and albuminuria may contribute to low bone mineral density. Copyright (C) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:589 / 595
页数:7
相关论文
共 37 条
[1]   Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: Relationship to microvascular complications and bone mineral density [J].
AboElAsrar, Mohammed A. ;
Elbarbary, Nancy S. ;
Elshennawy, Dina E. ;
Omar, Amin M. .
CYTOKINE, 2012, 59 (01) :86-93
[2]   13. Diabetes Care in the Hospital [J].
不详 .
DIABETES CARE, 2016, 39 :S99-S104
[3]   Glycemic Targets [J].
不详 .
DIABETES CARE, 2015, 38 :S33-S40
[4]   Clinical Report-Bone Densitometry in Children and Adolescents [J].
Bachrach, Laura K. ;
Sills, Irene N. .
PEDIATRICS, 2011, 127 (01) :189-194
[5]   Bone Mineral Density in Children and Adolescents With Prader-Willi Syndrome: A Longitudinal Study During Puberty and 9 Years of Growth Hormone Treatment [J].
Bakker, N. E. ;
Kuppens, R. J. ;
Siemensma, E. P. C. ;
van Wijngaarden, R. F. A. Tummers-de Lind ;
Festen, D. A. M. ;
Bindels-de Heus, G. C. B. ;
Bocca, G. ;
Haring, D. A. J. P. ;
Hoorweg-Nijman, J. J. G. ;
Houdijk, E. C. A. M. ;
Jira, P. E. ;
Lunshof, L. ;
Odink, R. J. ;
Oostdijk, W. ;
Rotteveel, J. ;
Van Alfen, A. A. E. M. ;
Van Leeuwen, M. ;
Van Wieringen, H. ;
Wegdam-den Boer, M. E. J. ;
Zwaveling-Soonawala, N. ;
Hokken-Koelega, A. C. S. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (04) :1609-1618
[6]   WNT signaling in bone homeostasis and disease: from human mutations to treatments [J].
Baron, Roland ;
Kneissel, Michaela .
NATURE MEDICINE, 2013, 19 (02) :179-192
[7]   Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus [J].
Brandao, Flavia R. ;
Vicente, Eliezer J. ;
Daltro, Carla H. ;
Sacramento, Marisa ;
Moreira, Agnaluce ;
Adan, Luis .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 78 (03) :334-339
[8]  
Dhaon Pooja, 2014, Indian J Endocrinol Metab, V18, P159, DOI 10.4103/2230-8210.129105
[9]  
Guntur Anyonya R, 2013, Bonekey Rep, V2, P437, DOI 10.1038/bonekey.2013.171
[10]   Bone, sweet bone-osteoporotic fractures in diabetes mellitus [J].
Hamann, Christine ;
Kirschner, Stephan ;
Guenther, Klaus-Peter ;
Hofbauer, Lorenz C. .
NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (05) :297-305